You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 83 The prognostic significance of peripheral blood biomarkers in patients with advanced non-small cell lung cancer treated with pembrolizumab: a clinical study

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
83 The prognostic significance of peripheral blood biomarkers in patients with advanced non-small cell lung cancer treated with pembrolizumab: a clinical study

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 202076014
Dec 202034013
Jan 20213002
Feb 20212404
Mar 202126010
Apr 20212403
May 20211509
Jun 2021005
Jul 20210011
Aug 2021005
Sep 2021005
Oct 202140018
Nov 202126016
Dec 20211603
Jan 20221003
Feb 20221604
Mar 20222204
Apr 20224403
May 20221801
Jun 20221601
Jul 20222002
Aug 2022803
Sep 20221601
Oct 20221002
Nov 20222401
Dec 20221001
Jan 2023601
Feb 20231400
Mar 20231409
Apr 2023602
May 20231201
Jun 20231600
Jul 2023804
Aug 20231402
Sep 20231201
Oct 2023602
Nov 20231601
Dec 20233201
Jan 2024203
Feb 20241200
Mar 20241402
Apr 2024404
May 20242402
Jun 20241800
Jul 20241200
Aug 20241001
Sep 20241603
Oct 20241205
Nov 20241402
Dec 2024801
Jan 2025603
Feb 2025001
Apr 2025009
May 2025003
Jun 2025005
Total8330212